Funder
Idex Sorbonne Universités Pour l’Enseignement et la Recherche (SUPER)
Publisher
Springer Science and Business Media LLC
Subject
Health, Toxicology and Mutagenesis,Public Health, Environmental and Occupational Health
Reference73 articles.
1. Brouwer R, Cauchi J, Verhoven J. Regulatory decision-making under uncertainty: are costs proportionate to benefits when restricting dangerous chemicals on European markets ? Regul Toxicol Pharmacol. 2014;68:438–46.
2. Rijk I, Van Duursen M, van den Berg M. Health costs that may be associated with endocrine disrupting chemicals : an inventory, evaluation and way forward to assess the potential socio-economic impact of EDC-associated health effects in the EU. Institute Risk Assessment Sci. 2016; http://www.uu.nl/sites/default/files/rijk_et_al_2016_-_report_iras_-_health_cost_associated_with_edcs_3.pdf . Accessed 20 Aug 2016
3. ECHA. Guidance on the preparation of socio-economic analysis as part of an application for authorisation. Version 1. 2011. https://echa.europa.eu/documents/10162/23036412/sea_authorisation_en.pdf/aadf96ec-fbfa-4bc7-9740-a3f6ceb68e6e . Accessed 30 May 2017.
4. Bellanger M, Demeneix B, Grandjean P, Zoeller RT, Trasande L. Neurobehavioral deficits, diseases and associated costs of exposure to endocrine disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100(4):1256–66.
5. Trasande L, Zoeller RT, Hass U, Kortenkamp A, Grandjean P, Myers JP, et al. Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European Union. J Clin Endocrinol Metab. 2015;100(4):1245–55.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献